These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 38679209)

  • 1. ONC212 enhances YM155 cytotoxicity by triggering SLC35F2 expression and NOXA-dependent MCL1 degradation in acute myeloid leukemia cells.
    Chiou JT; Chang LS
    Biochem Pharmacol; 2024 Jun; 224():116242. PubMed ID: 38679209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic cytotoxicity of decitabine and YM155 in leukemia cells through upregulation of SLC35F2 and suppression of MCL1 and survivin expression.
    Chiou JT; Chang LS
    Apoptosis; 2024 Apr; 29(3-4):503-520. PubMed ID: 38066391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of Sp1-mediated survivin and MCL1 expression cooperates with SLC35F2 and myeloperoxidase to modulate YM155 cytotoxicity to human leukemia cells.
    Chiou JT; Lee YC; Huang CH; Wang LJ; Shi YJ; Chang LS
    Biochem Pharmacol; 2021 Jun; 188():114544. PubMed ID: 33831396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NOXA-mediated degradation of MCL1 and BCL2L1 causes apoptosis of daunorubicin-treated human acute myeloid leukemia cells.
    Chiou JT; Huang NC; Huang CH; Wang LJ; Lee YC; Shi YJ; Chang LS
    J Cell Physiol; 2021 Nov; 236(11):7356-7375. PubMed ID: 33982799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BCL2 inhibitor ABT-199 and BCL2L1 inhibitor WEHI-539 coordinately promote NOXA-mediated degradation of MCL1 in human leukemia cells.
    Chiou JT; Lee YC; Wang LJ; Chang LS
    Chem Biol Interact; 2022 Jul; 361():109978. PubMed ID: 35561756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autophagic HuR mRNA degradation induces survivin and MCL1 downregulation in YM155-treated human leukemia cells.
    Chiou JT; Lee YC; Huang CH; Shi YJ; Wang LJ; Chang LS
    Toxicol Appl Pharmacol; 2020 Jan; 387():114857. PubMed ID: 31837377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytarabine-induced destabilization of MCL1 mRNA and protein triggers apoptosis in leukemia cells.
    Chiou JT; Hsu CC; Hong YC; Lee YC; Chang LS
    Biochem Pharmacol; 2023 May; 211():115494. PubMed ID: 36924905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BCL2L1 inhibitor A-1331852 inhibits MCL1 transcription and triggers apoptosis in acute myeloid leukemia cells.
    Chiou JT; Wu YY; Lee YC; Chang LS
    Biochem Pharmacol; 2023 Sep; 215():115738. PubMed ID: 37562509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AML sensitivity to YM155 is modulated through AKT and Mcl-1.
    de Necochea-Campion R; Diaz Osterman CJ; Hsu HW; Fan J; Mirshahidi S; Wall NR; Chen CS
    Cancer Lett; 2015 Sep; 366(1):44-51. PubMed ID: 26118775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GSK3β suppression inhibits MCL1 protein synthesis in human acute myeloid leukemia cells.
    Lee YC; Shi YJ; Wang LJ; Chiou JT; Huang CH; Chang LS
    J Cell Physiol; 2021 Jan; 236(1):570-586. PubMed ID: 32572959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. YM155 induces caspase-8 dependent apoptosis through downregulation of survivin and Mcl-1 in human leukemia cells.
    Feng W; Yoshida A; Ueda T
    Biochem Biophys Res Commun; 2013 May; 435(1):52-7. PubMed ID: 23618862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Confounding off-target effects of BH3 mimetics at commonly used concentrations: MIM1, UMI-77, and A-1210477.
    Mallick DJ; Soderquist RS; Bates D; Eastman A
    Cell Death Dis; 2019 Feb; 10(3):185. PubMed ID: 30796196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The suppressive effect of arsenic trioxide on TET2-FOXP3-Lyn-Akt axis-modulated MCL1 expression induces apoptosis in human leukemia cells.
    Chen YJ; Huang CH; Shi YJ; Lee YC; Wang LJ; Chang LS
    Toxicol Appl Pharmacol; 2018 Nov; 358():43-55. PubMed ID: 30213730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MLN4924 induces Noxa upregulation in acute myelogenous leukemia and synergizes with Bcl-2 inhibitors.
    Knorr KL; Schneider PA; Meng XW; Dai H; Smith BD; Hess AD; Karp JE; Kaufmann SH
    Cell Death Differ; 2015 Dec; 22(12):2133-42. PubMed ID: 26045051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CREB/Sp1-mediated MCL1 expression and NFκB-mediated ABCB1 expression modulate the cytotoxicity of daunorubicin in chronic myeloid leukemia cells.
    Chiou JT; Huang CH; Wu TH; Wang LJ; Lee YC; Huang PW; Chang LS
    Toxicol Appl Pharmacol; 2022 Jan; 435():115847. PubMed ID: 34963561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin K2 sensitizes the efficacy of venetoclax in acute myeloid leukemia by targeting the NOXA-MCL-1 pathway.
    Tauchi T; Moriya S; Okabe S; Kazama H; Miyazawa K; Takano N
    PLoS One; 2024; 19(7):e0307662. PubMed ID: 39052583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Novel MCL1 Inhibitor Combined with Venetoclax Rescues Venetoclax-Resistant Acute Myelogenous Leukemia.
    Ramsey HE; Fischer MA; Lee T; Gorska AE; Arrate MP; Fuller L; Boyd KL; Strickland SA; Sensintaffar J; Hogdal LJ; Ayers GD; Olejniczak ET; Fesik SW; Savona MR
    Cancer Discov; 2018 Dec; 8(12):1566-1581. PubMed ID: 30185627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydroquinone-selected chronic myelogenous leukemia cells are sensitive to chloroquine-induced cytotoxicity via MCL1 suppression and glycolysis inhibition.
    Chiou JT; Lee YC; Chang LS
    Biochem Pharmacol; 2023 Dec; 218():115934. PubMed ID: 37989415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amsacrine-induced apoptosis of human leukemia U937 cells is mediated by the inhibition of AKT- and ERK-induced stabilization of MCL1.
    Lee YC; Chen YJ; Huang CH; Chang LS
    Apoptosis; 2017 Mar; 22(3):406-420. PubMed ID: 27757735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MK-2206 induces apoptosis of AML cells and enhances the cytotoxicity of cytarabine.
    Lu JW; Lin YM; Lai YL; Chen CY; Hu CY; Tien HF; Ou DL; Lin LI
    Med Oncol; 2015 Jul; 32(7):206. PubMed ID: 26087957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.